Additive beneficial effect of folic acid and vitamin B12 co-administration on arsenic-induced oxidative damage in cardiac tissue In Vivo

Asian Journal of Pharmaceutical and Clinical Research

Volumn 6, Issue SUPPL.1, 2013, Pages 64-69

  Bhattacharjee, Surajit ^a   Sarkar, Chaitali ^a   Pal, Sudipta ^a  

^a TRIPURA UNIVERSITY   (India)

Author keywords

Cardiac toxicity; Folic acid; Oxidative stress; Sodium arsenite; Vitamin B12

Indexed keywords

ARSENIC; CATALASE; CYANOCOBALAMIN; FOLIC ACID; GLUTATHIONE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG EXPOSURE; ENZYME ACTIVITY; HEART; HEART PROTECTION; IN VIVO STUDY; LIPID PEROXIDATION; MALE; NONHUMAN; OXIDATIVE STRESS; PROTEIN CONTENT; RAT; TISSUE HOMOGENATE; VITAMIN SUPPLEMENTATION;

EID: 84877761268     PISSN: 09742441     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (52)

1. Goebel HH, Schmidt PF, Bohl J, Tettenborn B, Kramer G, Gutmann L. Polyneuropathy due to acute arsenic intoxication: biopsy studies. J Neuropathol Exp Neurol. 1990;49:137-49.
2. Jollife DM, Budd AJ, Gwilt DJ. Massive acute arsenic poisoning. Anaesthesis. 1991;46:288-90.
3. Neiger RD, Osweiler GD. Effect of subacute low level dietary sodium arsenite on dogs. Fundam Appl Toxicol. 1989;13:439-51.
4. Chen CJ, Chen CW, Wu MM, Kuo TL. Cancer potential in liver, lung, bladder and kidney due to ingested inorganic arsenic in drinking water. Br J Cancer. 1992;66:888-92.
5. Pal S, Chatterjee AK. Possible beneficial effects of melatonin supplementation on arsenic-induced oxidative stress in Wister rats. Drug Chem Toxicol. 2004;29:423-33.
6. Pal S, Chatterjee AK. Prospective protective role of melatonin against arsenic-induced metabolic toxicity in Wistar rats. Toxicol. 2005;208:25-3.
7. Kumagai Y, Sumi D. Arsenic: signal transduction, transcription factor, and biotransformation involved in cellular response and toxicity. Annu Rev Pharmacol Toxicol. 2007;47:243-62.
8. Bandopadhyay D, Chattopadhyay A. Reactive oxygen species - induced gastric ulceration: protection by melatonin. Curr Med Chem. 2006;13:1187-202.
9. Schlenk D, Wolford L, Chetius M. Effect of arsenite, arsenate and the herbicide monosodium methyl arsonate and lipid peroxidation in channel catfish. Comp Biochem Physiol C Pharmacol Toxicol Endocrinol. 1997;118:177-83.
10. Katz AM, Messineo FC. Lipid-membrane interactions and the pathogenesis of ischemic damage in the myocardium. Circ Res. 1981;48:1-6.
11. Hoorn CM. Environmental toxicants and endothelial function. Crisp Data Base National Institute of Health; 1995.
12. Wang CH, Hsiao CK, Chen CL, Hsu LI, Chiou HY, Chen SY, Hsueh YM, Wu MM, Chen CJ. A review of the epidemiologic literature on the role of environmental arsenic exposure and cardiovascular diseases. Toxicol Appl Pharmacol. 2006;222:315-26.
13. Tseng CH. Cardiovascular disease in arsenic-exposed subjects living in the arseniasis-hyperendemic areas in Taiwan. Atherosclerosis. 2008;199:12-8.
14. Chang CC, Ho SC, Tsai SS, Yang CY. Ischemic heart disease mortality reduction in an arseniasis-endemic area in southwestern Taiwan after a switch in the tap-water supply system. J Toxicol Environ Health A. 2004;67:1353-361.
15. Saad SY, Alkharfy KM, Arafah MM. Cardiotoxic effects of arsenic trioxide/imatinib mesilate combination in rats. J Pharm Pharmacol. 2006;58:567-73.
16. Raghu KG, Yadav GK, Singh R. Evaluation of cardiac effects induced by arsenic trioxide, a potent anti-APL drug. J Environ Pathol Toxicol Oncol. 2009;28:241-52.
17. Mordukhovich I, Wright RO, Amarasiriwardena C. Association between low-level environmental exposure and QT interval duration in a general population study. Am J Epidemiol. 2009;170:739-46.
18. Gey KF, Puska P, Jordan P. Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross - cultural epidemiology. Am J Clin Nutr. 1991;53:326S-34S.
19. Ramanathan K, Balakumar BS, Panneerselvam C. Effects of ascorbic acid and alpha-tocopherol on arsenic-induced oxidative stress. Hum Exp Toxicol. 2002;21:675-80.
20. Wilcox AJ, Lie RT, Solvoll K, Taylor J, McConnaughey DR, Abyholm F, Vindenes H, Vollset SE, Drevon CA. Folic acid supplements and risk of facial clefts: national population based case-control study. B M J (Clinical research ed). 2007;334:464.
21. Bazzano LA. Folic acid supplementation and cardiovascular disease: the state of the art. The Am J Med Sci. 2009;338:48-9.
22. 12 "Cobalamin". In: William & Wilkins (eds) Shits Medical Nutrition in Health and Diseases, 9th edn. Baltimore; 1999,447-58.
23. 12 in reduction of risk of Cardiovascular Diseases. Lancet. 2002;359:227-28.
24. 12 and Homocysteine. Mutat Res. 1999;428:299-04.
25. 12 and pyridoxal 5-phoshate (B6) and breast cancer. Cancer Epidemiol Biomarkers Prev. 1999;8:209-17.
26. Hathcock JN. Vitamins and minerals: efficacy and safety. Am J Clin Nutr. 1997;66:427-37.
27. Gallo-Torres DC. Absorption, blood transport and metabolism of vitamin E. In: Machlin LJ (ed) A Comprehensive Treatise. Marcel Dekker, New York; 1980,170-67.
28. Pal S, Chatterjee AK. Possible beneficial effects of melatonin supplementation on arsenic-induced oxidative stress in Wistar rats. Drug Chem Toxicol. 2006;29:423-33.
29. Ellman GL. Tissue sulfhydryl groups. Arch Biochem. 1959;82:70-7.
30. Davila JC, Davis PJ, Acosta D. Changes in glutathione cellular energy as potential mechanisms of papaverine-induced hepatptotoxicity in vitro. Toxicol Appl Pharmacol. 1991;108:28-6.
31. Buege A, Aust SD. Microsomal lipid peroxidation. Methods Enzymol. 1978;52:302-10.
32. Maiti S, Chatterjee AK. Differential response of cellular antioxidant mechanism of liver and kidney to arsenic exposure and its relation to dietary protein deficiency. Environ Toxicol Pharmacol. 2000;8:227-35.
33. Raso GM, Meli R, Gualillo O. Prolactin induction of nitric oxide synthase in rat C6 glioma cells. J Neurochem. 1999;73: 2272-277.
34. Carlberg I, Mannervavik B. Glutathione reductase. Methods Enzymol. 1985;113:484-85.
35. Warholm M, Guthenberg C, Bahr CV. Glutathione s-transferase from human liver. Methods Enzymol. 1985;113:499-02.
36. Aebi H. Catalase in vitro. Methods Enzymol. 1984;105:121-26.
37. Martin JP, Dailey M, Sugarman E. Negetive and positive assay of superoxide dismutase based on hematoxylin autooxidation. Arch Biochem Biophys. 1987;255:329-36.
38. Lowry OH, Rosebrough NJ, Farr AL. Protein measurement with the Folin phenol reagnt. J Biol Chem. 1951;193:265-75.
39. Das D. Statistics in Biology and Psychology, Academic Publishers, Calcutta, New Delhi, 1981;pp. 197.
40. Thompson DJ. A chemical hypothesis for arsenic methylation in mammals. Chem Biol Interact. 1993;88:89-14.
41. Hunter ES. Mechanisms of developmental toxicity. Crisp Data Base National Institute of Health; 1993.
42. Rana JS, Ahmad KA, Shamim AS, Hassan SB, Ahmed MA. Blalock-Taussig shunt: experience from the developing world. Heart Lung Circ. 2002;11:152-56.
43. Manna P, Sinha M, Sil, PC. Arsenic-induced oxidative myocardial injury: protective role of arjunolic acid. Arch Toxicol. 2008;82:137-49.
44. Das AK, Sahu R, Dua TK. Arsenic-induced myocardial injury: protective role of Corchorus olitorius leaves. Food Chem Toxicol. 2010;48:1210-217.
45. Halliwell B. Free radicals and antioxidants: A personal view. Nutr Rev. 1994;52:253-65.
46. Whaley-Connell A, Sowers JR. Oxidative stress in the cardiorenal metabolic syndrome. Curr Hepertens Rep. 2012;[Epub ahead of print].
47. Lynn S, Shiung JN, Gurr JR. Arsenite stimulates poly ADP-ribosylation by generation of nitric oxide. Free Radic Biol Med. 1998;24:442-49.
48. Matsui M, Nishigori C, Toyokuni S. The role of oxidative DNA damage in human arsenic carcinogenic: detection of 8-hydroxy-2-deoxyguanosinme in arsenic-related Bowen's disease. J Invest Dermatol. 1999;113:26-1.
49. Styblo M, Thomas TJ. Factors influencing in vitro methylation of arsenicals in rat liver cytosol. In: Abernathy CO, Calderon RL, Chappell WR (eds) Arsenic Exposure and Health Effects. Chapman and Hall, London, 1997; pp. 283-95.
50. Sahin K, Onderci M, Sahin N, Gursu MF, Kucuk O. Dietary vitamin C and folic acid supplementation ameliorates the detrimental effects of heat stress in Japanese quail. J Nutr. 2003;133:1882-886.
51. Bannerjee RV, Matthews RG. Cobalamin-dependent methionine synthesis. FASEB J. 1990;4:1450-459.
52. Jing M, Meir J, Stampfer, Benedicte C, Edward G, David JH, Jia C, Walter CW, Jacob S, Charles HH, Roy G, and Rima R. A Polymorphism of the Methionine Synthase Gene: Association with Plasma Folate, Vitamin B12, Homocysteine, and Colorectal Cancer Risk. Cancer Epidemiol Biomarkers. 1999;8:825-29.